TrendFlares logo

MacroGenics, Inc. (MGNX)

$3.39 2.73% $0.09 Healthcare

MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecific CD123 × CD3 DART molecule to minimize cytokine-release syndrome for patients with hematologic malignancies. It also develops Lorigerlimab, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3; Retifanlimab, an investigational monoclonal antibody targeting metastatic squamous cell carcinoma of the anal canal and metastatic non-small cell lung cancer; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. Further, the company develops MGD014 and MGD020, a DART molecule to target the envelope protein of human immunodeficiency virus infected cells and CD3 on T cells; Teplizumab for the treatment of type 1 diabetes; and PRV-3279, a CD32B × CD79B DART molecule for the treatment of autoimmune indications. It has collaborations with Incyte Corporation; Zai Lab Limited; I-Mab Biopharma; and Janssen Biotech, Inc. The company was incorporated in 2000 and is headquartered in Rockville, Maryland.

$212.63M

Dr. Scott Koenig M.D., Ph.D.

427.00

Rockville, MD

Oct 10, 2013

-1.55

$-2.19

1.45

2.71

-332.47%

-1.56

-0.08

3.67

5.18

2.69

-67.80%

-106.84%

Downtrend

Similar stocks (15)

Edgewise Therapeutics, Inc.

EWTX

$29.50 54.69%
Uptrend

Protagonist Therapeutics, Inc.

PTGX

$45.92 2.57%
Uptrend

Syndax Pharmaceuticals, Inc.

SNDX

$18.63 3.50%
Downtrend

Tyra Biosciences, Inc.

TYRA

$23.99 3.41%
Uptrend

Day One Biopharmaceuticals, Inc.

DAWN

$14.32 3.84%
Downtrend

Cullinan Oncology, Inc.

CGEM

$17.94 4.12%
Downtrend

C4 Therapeutics, Inc.

CCCC

$6.57 2.98%
Neutral

Monte Rosa Therapeutics, Inc.

GLUE

$6.25 5.04%
Neutral

Nkarta, Inc.

NKTX

$5.38 2.09%
Downtrend

Inozyme Pharma, Inc.

INZY

$5.78 -0.52%
Uptrend

PepGen Inc.

PEPG

$9.35 0.97%
Downtrend

Century Therapeutics, Inc.

IPSC

$1.70 3.03%
Downtrend

PMV Pharmaceuticals, Inc.

PMVP

$1.52 0.66%
Downtrend

Kezar Life Sciences, Inc.

KZR

$0.58 1.08%
Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.08 1.89%
Downtrend

ETF Exposure (40)

Loncar Cancer Immunotherapy ETF

CNCR

3.17%

$15.77 2.40%
Uptrend

Invesco NASDAQ Future Gen 200 ETF

QQQS

0.412%

$27.51 1.81%
Uptrend

iShares Genomics Immunology and Healthcare ETF

IDNA

0.22068%

$25.12 0.94%
Uptrend

iShares Micro-Cap ETF

IWC

0.05496%

$126.54 2.19%
Uptrend

BlackRock Future Health ETF

BMED

0.03148%

$26.68 1.55%
Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.021%

$24.66 1.07%
Uptrend

iShares Biotechnology ETF

IBB

0.01835%

$149.47 1.32%
Uptrend

iShares Russell 2000 Growth ETF

IWO

0.01384%

$285.77 2.18%
Uptrend

Vanguard Horizon Funds - Vanguard Strategic Equity Fund

VSEQX

0.01%

$39.87 1.84%
Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0.01%

$208.30 2.26%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$90.58 2.07%
Uptrend

iShares Russell 2000 ETF

IWM

0.00815%

$223.97 2.06%
Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.0073125912%

$51.96 1.90%
Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.006107757278510079%

$68.23 2.32%
Uptrend

Dimensional U.S. Small Cap ETF

DFAS

0.00583971%

$65.11 2.13%
Uptrend

ProShares Ultra Russell2000

UWM

0.0030771257398705147%

$44.09 4.26%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.00278%

$170.39 1.83%
Uptrend

ProShares UltraPro Russell2000

URTY

0.0015176941471999343%

$54.27 6.25%
Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

0.0013935899999999999%

$34.14 1.82%
Uptrend

ProShares Hedge Replication ETF

HDG

0.0012863397809732581%

$50.07 0.41%
Uptrend

Schwab U.S. Broad Market ETF

SCHB

4.647136e-4%

$66.24 1.72%
Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

4.5e-4%

$125.25 1.78%
Uptrend

iShares Russell 3000 ETF

IWV

3.9e-4%

$325.63 1.75%
Uptrend

WisdomTree U.S. SmallCap Earnings Fund

EES

2.951e-4%

$53.68 2.38%
Uptrend

Dimensional US Core Equity Market ETF

DFAU

2.6264e-4%

$39.40 1.78%
Uptrend

Dimensional U.S. Equity ETF

DFUS

2.2703e-4%

$61.75 1.80%
Uptrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

0%

$70.22 2.36%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.96 1.07%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.95 1.07%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.94 1.05%
Uptrend

Vanguard Health Care Index Fund

VHT

0%

$286.45 0.57%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$138.77 2.02%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$97.80 1.74%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$97.78 1.74%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$253.06 1.86%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$282.05 1.69%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0%

$150.33 1.93%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$182.92 2.00%
Uptrend